<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Risk of Severe COVID-19 Infection in Pediatric Patients With MS on B-Cell-Depleting Therapies

Default sub title

minute read

by Neurology Live | May 14, 2023
placeholder

Immunosuppressants are commonly used to treat pediatric patients with multiple sclerosis (MS) and related disorders such as clinically isolated syndrome (CIS), myelin oligodendrocyte glycoprotein antibody disorder (MOGAD), and neuromyelitis optica spectrum disorder (NMOSD). 

Topics: Press Coverage